# The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

> **NCT00001087** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 300 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Nelfinavir mesylate
- **DRUG:** Efavirenz
- **DRUG:** Levocarnitine
- **DRUG:** Adefovir dipivoxil
- **DRUG:** Saquinavir
- **DRUG:** Lamivudine
- **DRUG:** Stavudine
- **DRUG:** Zidovudine
- **DRUG:** Zalcitabine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00001087
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2000-07
- **Target enrollment:** 300 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001087, "The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00001087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*